Search research articles
Contact Us
Filters
Showing results (171-180 of 229) with videos related to
Page
of 23
Sort By:
Ebiomedicine
|
March 5, 2019
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study
C Mirjolet, J L Merlin, G Truc, et al.
ESMO Open
|
September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer
A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Gynecologic Oncology
|
March 26, 2016
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072
C Benson, I Ray-Coquard, S Sleijfer, et al.
Gynecologic Oncology
|
May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy
I Ray-Coquard, E Rizzo, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2012
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
I Ray-Coquard, M C Montesco, J M Coindre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours
A F Leary, M Quinn, K Fujiwara, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
H Gelderblom, J Y Blay, B M Seddon, et al.
British Journal of Cancer
|
February 5, 2009
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
I Ray-Coquard, B Weber, J Cretin, et al.
Microbiology Resource Announcements
|
March 6, 2024
Genome sequences of actinobacteriophages JorRay, Blocker23, Nibbles, and OlgasClover
Breanna M Baumgartner, Kayla A Bono, Dawn R McIntosh, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 229) with videos related to
Sort By:
Page
of 23
Ebiomedicine
|
March 5, 2019
RILA blood biomarker as a predictor of radiation-induced sarcoma in a matched cohort study
C Mirjolet, J L Merlin, G Truc, et al.
ESMO Open
|
September 4, 2024
Efficacy of chemotherapy after progression during or following PARPi exposure in ovarian cancer
A Xu-Vuillard, C Guerin-Charbonnel, F Bocquet, et al.
Gynecologic Oncology
|
March 26, 2016
Outcome of uterine sarcoma patients treated with pazopanib: A retrospective analysis based on two European Organisation for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group (STBSG) clinical trials 62043 and 62072
C Benson, I Ray-Coquard, S Sleijfer, et al.
Gynecologic Oncology
|
May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapy
I Ray-Coquard, E Rizzo, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 9, 2013
Advanced chondrosarcomas: role of chemotherapy and survival
A Italiano, O Mir, A Cioffi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2012
Sarcoma: concordance between initial diagnosis and centralized expert review in a population-based study within three European regions
I Ray-Coquard, M C Montesco, J M Coindre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 21, 2016
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours
A F Leary, M Quinn, K Fujiwara, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 13, 2013
Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
H Gelderblom, J Y Blay, B M Seddon, et al.
British Journal of Cancer
|
February 5, 2009
Gemcitabine-oxaliplatin combination for ovarian cancer resistant to taxane-platinum treatment: a phase II study from the GINECO group
I Ray-Coquard, B Weber, J Cretin, et al.
Microbiology Resource Announcements
|
March 6, 2024
Genome sequences of actinobacteriophages JorRay, Blocker23, Nibbles, and OlgasClover
Breanna M Baumgartner, Kayla A Bono, Dawn R McIntosh, et al.
Page
of 23